MarketCap
Atossa Therapeutics ATOS
€ 1.97
1.38%
Facebook
X
Telegram
Atossa Therapeutics ROCE | ATOS
ROCE Jährlich Atossa Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -94.38 | -38.64 | -34.47 | -23.47 | -14.86 | -65.62 | -131.13 | -129.86 | -103.59 | -234.08 | -340.98 | -128.69 | -101.73 | -97.94 | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -14.86 | -340.98 | -109.96 |
ROCE Vierteljährlich Atossa Therapeutics
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -120.98 | -112.42 | -95.69 | -74.66 | -55.6 | -45.69 | -38.88 | -35.67 | -35.58 | -34.51 | -33.08 | -31.21 | -27.92 | -25.39 | -21.47 | -15.2 | -18.85 | -17.09 | -14.55 | -11.04 | -26.59 | -58.48 | -100.59 | -125.0 | -134.52 | -140.43 | -124.35 | -97.42 | -135.01 | -156.99 | -140.68 | -109.79 | -139.42 | -129.15 | -106.66 | -81.51 | -131.83 | -173.66 | -208.02 | -183.46 | -249.58 | -241.66 | -194.31 | -164.35 | -133.26 | -111.21 | -103.9 | -82.9 | -80.9 | -84.93 | -86.43 | -75.71 | -97.65 | -87.15 | -83.3 | -64.99 | -146.68 | -22.53 | -20.52 | - | -81.69 | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -11.04 | -249.58 | -93.04 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Eyenovia
EYEN
|
-113.79 | - | 49.81 % | $ 13.2 M |  USA |
 |
FibroGen
FGEN
|
152.79 | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
33.52 | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
11.96 | - | - | $ 4.47 B | USA |
 |
Frequency Therapeutics
FREQ
|
-119.97 | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
-87.69 | - | - | $ 762 M |  Danmark |
 |
GlycoMimetics
GLYC
|
-75.18 | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
-235.71 | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
-63.97 | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
-44.94 | - | 1.35 % | $ 17.8 M |  China |
 |
Novavax
NVAX
|
63.19 | $ 10.15 | -6.8 % | $ 1.64 B | USA |
 |
Hepion Pharmaceuticals
HEPA
|
-156.09 | - | -18.79 % | $ 39.3 K | USA |
 |
Hoth Therapeutics
HOTH
|
-200.97 | - | - | $ 18.8 M | USA |
 |
IMARA
IMRA
|
-26.04 | - | 15.96 % | $ 663 M | USA |
 |
KalVista Pharmaceuticals
KALV
|
-104.22 | - | - | $ 1.45 B |  Britain |
 |
KemPharm
KMPH
|
-25.64 | - | -0.34 % | $ 200 M | USA |
 |
Kezar Life Sciences
KZR
|
-84.35 | - | - | $ 53.3 M | USA |
 |
Lixte Biotechnology Holdings
LIXT
|
-52.85 | - | - | $ 63.4 M | USA |
 |
Magenta Therapeutics
MGTA
|
-35.57 | - | -7.74 % | $ 41.6 M | USA |
 |
NovaBay Pharmaceuticals
NBY
|
-111.88 | - | - | $ 11.3 M | USA |
 |
NeuroBo Pharmaceuticals
NRBO
|
-257.04 | - | 0.43 % | $ 12 M | USA |
 |
OncoCyte Corporation
OCX
|
162.48 | - | 17.22 % | $ 355 K | USA |
 |
Onconova Therapeutics
ONTX
|
2841.81 | - | -0.47 % | $ 21 M | USA |
 |
Opthea Limited
OPT
|
77.47 | - | - | $ 1.2 B |  Australia |
 |
Verastem
VSTM
|
-97.68 | $ 8.74 | 0.52 % | $ 606 M | USA |
|
BiomX
PHGE
|
6957.38 | $ 1.85 | 14.2 % | $ 3.02 M |  Israel |
 |
Pieris Pharmaceuticals
PIRS
|
-80.06 | - | -15.58 % | $ 1.22 B |  Germany |
 |
Plus Therapeutics
PSTV
|
-382.83 | - | - | $ 301 M | USA |
 |
Pluristem Therapeutics
PSTI
|
185.51 | - | -1.9 % | $ 33.3 M | Israel |
 |
Qualigen Therapeutics
QLGN
|
-47.23 | - | 5.59 % | $ 1.16 M | USA |
|
Qilian International Holding Group Limited
QLI
|
-3.22 | - | -6.08 % | $ 184 M | China |
 |
Cassava Sciences
SAVA
|
-128.0 | - | - | $ 110 M | USA |
 |
Selecta Biosciences
SELB
|
-50.95 | - | -8.69 % | $ 126 M | USA |
 |
Sangamo Therapeutics
SGMO
|
849.73 | - | - | $ 50.4 M | USA |
 |
Salarius Pharmaceuticals
SLRX
|
-214.2 | - | - | $ 2.64 M | USA |
 |
Sensei Biotherapeutics
SNSE
|
-119.5 | - | - | $ 17.5 M | USA |
 |
Sonnet BioTherapeutics Holdings
SONN
|
-146.87 | - | - | $ 826 K | USA |
 |
Synthetic Biologics
SYN
|
-156.35 | - | 1.32 % | $ 16.2 M | USA |
 |
Synlogic
SYBX
|
-33.79 | - | - | $ 7.07 M | USA |
 |
Virios Therapeutics, LLC
VIRI
|
-32.11 | - | 2710.01 % | $ 72.9 M | USA |
 |
Vallon Pharmaceuticals
VLON
|
-199.35 | - | -6.47 % | $ 5.76 M | USA |
 |
Vaxart
VXRT
|
5.01 | - | -25.06 % | $ 46.3 M | USA |
 |
XOMA Corporation
XOMA
|
13.56 | - | - | $ 485 M | USA |
 |
Repare Therapeutics
RPTX
|
-61.88 | - | - | $ 112 M |  Canada |
 |
Sesen Bio
SESN
|
222.79 | - | 7.29 % | $ 127 M | USA |
|
Windtree Therapeutics
WINT
|
-261.49 | - | - | $ 26.8 M | USA |
 |
SQZ Biotechnologies Company
SQZ
|
-141.18 | - | 57.95 % | $ 12.8 M | USA |
 |
MEI Pharma
MEIP
|
-159.95 | - | 10.43 % | $ 20.5 M | USA |
 |
Palatin Technologies
PTN
|
-129.64 | - | - | $ 13 M | USA |